An observational study in Enterococcal Bacteremia, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 12 sites in 5 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-06-01.
Sponsored by The University of Texas Health Science Center, Houston · Observational
The purpose of this study is to assemble a multicenter prospective cohort of patients with enterococcal bloodstream infections (BSIs) to provide data on outcomes of patients with enterococcal BSIs for sample size calculations for future trials, as well as to characterize enterococcal isolates causing BSIs in order to comprehensively dissect the molecular epidemiology of infecting organisms for future studies.
Hospitalized patients
Exclusion Criteria:
Adult patients (≥ 18 years of age) with ≥ 1 positive blood cultures with Enterococcus during hospitalization and who have repeat blood culture(s) within 7 days from the first positive culture will be included.
All-cause, in-hospital mortality
Death by any cause while patient is in the hospital
Time frame: 30 days or until hospital discharge
Number of participants with microbiological outcome
Eradication defined as a negative follow-up blood culture \> 4 days after index blood culture
Time frame: 7 days after first documented positive blood culture
Number of participants with recurrence of bacteremia
Positive blood culture with the same organism within the following 14 days after the documented eradication of bacteremia
Time frame: 14 days after the documented eradication of bacteremia
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston